Eagle Pharmaceuticals
EGRX
$4.57
Share price
3.63%
Change (1 day)
-84.33%
Change (1 year)
Categories
EPS for Eagle Pharmaceuticals (EGRX)
EPS in 2023 (TTM): $0.92
According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.92. In 2022 the company made an earnings per share (EPS) of $2.82 an increase over its 2021 EPS that were of -$0.66.
EPS history for Eagle Pharmaceuticals from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.92 | -67.38% |
| 2022 | $2.82 | -527.27% |
| 2021 | -$0.66 | -174.16% |
| 2020 | $0.89 | -13.59% |
| 2019 | $1.03 | -52.75% |
| 2018 | $2.18 | -36.63% |
| 2017 | $3.44 | -35.09% |
| 2016 | $5.30 | 1792.86% |
| 2015 | $0.28 | -117.39% |
| 2014 | -$1.61 | 71.62% |
| 2013 | -$0.94 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | 1,431.01% | 🇺🇸 USA |
 Novartis NVS | $3.74 | 306.52% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $5.43 | 490.14% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 1,438.04% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | 331.52% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | 280.51% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -317.39% | 🇮🇱 Israel |